Nomenclature for human CYP2D6 alleles

被引:382
|
作者
Daly, AK
Brockmoller, J
Broly, F
Eichelbaum, M
Evans, WE
Gonzalez, FJ
Huang, JD
Idle, JR
IngelmanSundberg, M
Ishizaki, T
JacqzAigrain, E
Meyer, UA
Nebert, DW
Steen, VM
Wolf, CR
Zanger, UM
机构
[1] HUMBOLDT UNIV BERLIN, INST KLIN PHARMAKOL, KLINIKUM CHARITE, D-10098 BERLIN, GERMANY
[2] CTR HOSP REG & UNIV LILLE, HOP CALMETTE, LAB BIOCHIM & BIOL MOL, F-59037 LILLE, FRANCE
[3] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL, D-70376 STUTTGART, GERMANY
[4] ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT, MEMPHIS, TN 38101 USA
[5] NCI, MOLEC CARCINOGENESIS LAB, NIH, BETHESDA, MD 20892 USA
[6] NATL CHENG KUNG UNIV, DEPT PHARMACOL, TAINAN 70101, TAIWAN
[7] KAROLINSKA INST, DEPT MED BIOCHEM & BIOPHYS, S-17177 STOCKHOLM, SWEDEN
[8] INT MED CTR JAPAN, RES INST, DEPT CLIN PHARMACOL, SHINJUKU KU, TOKYO 162, JAPAN
[9] HOP ROBERT DEBRE, INSERM U120, F-75019 PARIS, FRANCE
[10] HOP ROBERT DEBRE, DEPT CLIN PHARMACOL, F-75019 PARIS, FRANCE
[11] UNIV BASEL, BIOCTR, ABT PHARMAKOL, CH-4056 BASEL, SWITZERLAND
[12] UNIV CINCINNATI, MED CTR, DEPT ENVIRONM HLTH, CINCINNATI, OH 45267 USA
[13] HAUKELAND HOSP, CTR MOL MED, DR EINAR MARTENS RES GRP BIOL PSYCHIAT, N-5021 BERGEN, NORWAY
[14] UNIV DUNDEE, NINEWELLS HOSP & MED SCH, BIOMED RES CTR, DUNDEE DD1 9SY, SCOTLAND
来源
PHARMACOGENETICS | 1996年 / 6卷 / 03期
关键词
allele nomenclature; CYP2D6;
D O I
10.1097/00008571-199606000-00001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To standardize CYP2D6 allele nomenclature, and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described, Based on recommendations for human genome nomenclature, we propose that alleles be designated by CYP2D6 followed by an asterisk and a combination of roman letters and arabic numerals distinct for each allele with the number specifying the key mutation and, where appropriate, a letter specifying additional mutations, Criteria for classification as a separate allele and protein nomenclature are also presented.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 50 条
  • [41] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [42] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [43] Evidence for CYP2D6 expression in human lung
    Lo Guidice, JM
    Marez, D
    Sabbagh, N
    Legrand-Andreoletti, M
    Spire, C
    Alcaïde, E
    Lafitte, JJ
    Broly, F
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (01) : 79 - 85
  • [44] Enantioselective metabolism of primaquine by human CYP2D6
    Pius S Fasinu
    Babu L Tekwani
    NP Dhammika Nanayakkara
    Bharathi Avula
    HMT Bandara Herath
    Yan-Hong Wang
    Vijender R Adelli
    Mahmoud A Elsohly
    Shabana I Khan
    Ikhlas A Khan
    Brandon S Pybus
    Sean R Marcsisin
    Gregory A Reichard
    James D McChesney
    Larry A Walker
    Malaria Journal, 13
  • [45] Enantioselective metabolism of primaquine by human CYP2D6
    Fasinu, Pius S.
    Tekwani, Babu L.
    Nanayakkara, N. P. Dhammika
    Avula, Bharathi
    Herath, H. M. T. Bandara
    Wang, Yan-Hong
    Adelli, Vijender R.
    Elsohly, Mahmoud A.
    Khan, Shabana I.
    Khan, Ikhlas A.
    Pybus, Brandon S.
    Marcsisin, Sean R.
    Reichard, Gregory A.
    McChesney, James D.
    Walker, Larry A.
    MALARIA JOURNAL, 2014, 13
  • [46] EXPRESSION OF CYP2D6 IN DEVELOPING HUMAN LIVER
    TRELUYER, JM
    JACQZAIGRAIN, E
    ALVAREZ, F
    CRESTEIL, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 202 (02): : 583 - 588
  • [47] CYP2D6 multiallelism
    Daly, AK
    Steen, VM
    Fairbrother, KS
    Idle, JR
    CYTOCHROME P450, PT B, 1996, 272 : 199 - 210
  • [48] Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
    Lundqvist, E
    Johansson, I
    Ingelman-Sundberg, M
    GENE, 1999, 226 (02) : 327 - 338
  • [49] Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes
    Kubota, T
    Yamaura, Y
    Ohkawa, N
    Hara, H
    Chiba, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (01) : 31 - 34
  • [50] Purification, biochemical characterization and comparative enzyme kinetics of recombinant human CYP2D6 1 and CYP2D6 2 variants
    Yu, AM
    Haining, RL
    BIOLOGICAL REACTIVE INTERMEDIATES VI: CHEMICAL AND BIOLOGICAL MECHANISMS IN SUSCEPTIBILITY TO AND PREVENTION OF ENVIRONMENTAL DISEASES, 2001, 500 : 327 - 330